|
1
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schiffer CA, Mangu PB, Wade JC,
Camp-Sorrell D, Cope DG, El-Rayes BF, Gorman M, Ligibel J,
Mansfield P and Levine M: Central venous catheter care for the
patient with cancer: American Society of Clinical Oncology clinical
practice guideline. J Clin Oncol. 31:1357–1370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turcotte S, Dube S and Beauchamp G:
Peripherally inserted central venous catheters are not superior to
central venous catheters in the acute care of surgical patients on
the ward. World J Surg. 30:1605–1619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Viart H, Combe C, Martinelli T, Thomas J
and Hida H: Comparison between implantation costs of peripherally
inserted central catheter and implanted subcutaneous ports. Ann
Pharm Fr. 73:239–244. 2015.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goltz JP, Noack C, Petritsch B, Kirchner
J, Hahn D and Kickuth R: Totally implantable venous power ports of
the forearm and the chest: Initial clinical experience with port
devices approved for high-pressure injections. Br J Radiol.
85:e966–e972. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alexander MD and Morrison HL:
Power-injectable ports: Safety during placement, therapeutic use,
and contrast administration during computed tomography procedures.
J Vasc Access. 13:432–437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kock HJ, Pietsch M, Krause U, Wilke H and
Eigler FW: Implantable vascular access systems: Experience in 1500
patients with totally implanted central venous port systems. World
J Surg. 22:12–16. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lorch H, Zwaan M, Kagel C and Weiss HD:
Central venous access ports placed by interventional radiologists:
Experience with 125 consecutive patients. Cardiovasc Intervent
Radiol. 24:180–184. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vardy J, Engelhardt K, Cox K, Jacquet J,
McDade A, Boyer M, Beale P, Stockler M, Loneragan R, Dennien B, et
al: Long-term outcome of radiological-guided insertion of implanted
central venous access port devices (CVAPD) for the delivery of
chemotherapy in cancer patients: Institutional experience and
review of the literature. Br J Cancer. 91:1045–1049. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biffi R, de Braud F, Orsi F, Pozzi S,
Mauri S, Goldhirsch A, Nolè F and Andreoni B: Totally implantable
central venous access ports for long-term chemotherapy. A
prospective study analyzing complications and costs of 333 devices
with a minimum follow-up of 180 days. Ann Oncol. 9:767–773. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fragou M, Gravvanis A, Dimitriou V,
Papalois A, Kouraklis G, Karabinis A, Saranteas T, Poularas J,
Papanikolaou J, Davlouros P, et al: Real-time ultrasound-guided
subclavian vein cannulation versus the landmark method in critical
care patients: A prospective randomized study. Crit Care Med.
39:1607–1612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mori Y, Nagayama S, Kawamura J, Hasegawa
S, Tanaka E, Okabe H, Takeuchi M, Sonobe M, Matsumoto S, Kanai M,
et al: A retrospective analysis on the utility and complications of
upper arm ports in 433 cases at a single institute. Int J Clin
Oncol. 21:474–482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shiono M, Takahashi S, Kakudo Y, Takahashi
M, Shimodaira H, Kato S and Ishioka C: Upper arm central venous
port implantation: A 6-Year single institutional retrospective
analysis and pictorial essay of procedures for insertion. PLoS One.
9:e913352014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Cai Y, Gan X, Ye X, Ling J, Kang L,
Ye J, Zhang X, Zhang J, Cai Y, et al: Application and comparison of
different implanted ports in malignant tumor patients. World J Surg
Oncol. 14:2512016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pikwer A, Åkeson J and Lindgren S:
Complications associated with peripheral or central routes for
central venous cannulation. Anaesthesia. 67:65–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Todd J: Peripherally inserted central
catheters and their use in i.v. therapy. Br J Nurs. 8:140-2,
144–146-8. 1999. View Article : Google Scholar
|
|
17
|
Ahn DH, Illum HB, Wang DH, Sharma A and
Dowell JE: Upper extremity venous thrombosis in patients with
cancer with peripherally inserted central venous catheters: A
retrospective analysis of risk factors. J Oncol Pract. 9:e8–e12.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aw A, Carrier M, Koczerginski J, McDiarmid
S and Tay J: Incidence and predictive factors of symptomatic
thrombosis related to peripherally inserted central catheters in
chemotherapy patients. Thromb Res. 130:323–326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang MJ, Ryoo BY, Ryu MH, Koo DH, Chang
HM, Lee JL, Kim TW and Kang YK: Venous thromboembolism (VTE) in
patients with advanced gastric cancer: An Asian experience. Eur J
Cancer. 48:492–500. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heit JA, Silverstein MD, Mohr DN,
Petterson TM, O'Fallon WM and Melton LJ III: Risk factors for deep
vein thrombosis and pulmonary embolism: A population-based
case-control study. Arch Intern Med. 160:809–815. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blom JW, Doggen CJ, Osanto S and Rosendaal
FR: Malignancies, prothrombotic mutations, and the risk of venous
thrombosis. JAMA. 293:715–722. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Gao Y, Wei L, Chen W, Ma X and Song
L: Peripherally inserted central catheter thrombosis incidence and
risk factors in cancer patients: A double-center prospective
investigation. Ther Clin Risk Manag. 11:153–160. 2015.PubMed/NCBI
|
|
23
|
Japanese Gastric Cancer Association, .
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akahane A, Sone M, Ehara S, Kato K, Tanaka
R and Nakasato T: Subclavian vein versus arm vein for totally
implantable central venous port for patients with head and neck
cancer: A retrospective comparative analysis. Cardiovasc Intervent
Radiol. 34:1222–1229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawamura J, Nagayama S, Nomura A, Itami A,
Okabe H, Sato S, Watanabe G and Sakai Y: Long-term outcomes of
peripheral arm ports implanted in patients with colorectal cancer.
Int J Clin Oncol. 13:349–354. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin WY, Lin CP, Hsu CH, Lee YH, Lin YT,
Hsu MC and Shao YY: Right or left? Side selection for a totally
implantable vascular access device: A randomised observational
study. Br J Cancer. 117:932–937. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Loughran SC and Borzatta M: Peripherally
inserted central catheters: A report of 2506 catheter days. JPEN J
Parenter Enteral Nutr. 19:133–136. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tran H, Arellano M, Chamsuddin A, Flowers
C, Heffner LT, Langston A, Lechowicz MJ, Tindol A, Waller E, Winton
EF and Khoury HJ: Deep venous thromboses in patients with
hematological malignancies after peripherally inserted central
venous catheters. Leuk Lymphoma. 51:1473–1477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Patel GS, Jain K, Kumar R, Strickland AH,
Pellegrini L, Slavotinek J, Eaton M, McLeay W, Price T, Ly M, et
al: Comparison of peripherally inserted central venous catheters
(PICC) versus subcutaneously implanted port-chamber catheters by
complication and cost for patients receiving chemotherapy for
non-haematological malignancies. Support Care Cancer. 22:121–128.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen IC, Hsu C, Chen YC, Chien SF, Kao HF,
Chang SY, Hu FC and Yeh KH: Predictors of bloodstream infection
associated with permanently implantable venous port in solid cancer
patients. Ann Oncol. 24:463–468. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ji L, Yang J, Miao J, Shao Q, Cao Y and Li
H: Infections related to totally implantable venous-access ports:
Long-term experience in one center. Cell Biochem Biophys.
72:235–240. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang TY, Lee KD, Chen PT, Chen MC, Chen
YY, Huang CE, Kuan FC, Chen CC and Lu CH: Incidence and risk
factors for central venous access port-related infection in Chinese
cancer patients. J Formos Med Assoc. 114:1055–1060. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuderer NM, Ortel TL and Francis CW:
Impact of venous thromboembolism and anticoagulation on cancer and
cancer survival. J Clin Oncol. 27:4902–4911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zakai NA, Wright J and Cushman M: Risk
factors for venous thrombosis in medical inpatients: Validation of
a thrombosis risk score. J Thromb Haemost. 2:2156–2161. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sallah S, Wan JY and Nguyen NP: Venous
thrombosis in patients with solid tumors: Determination of
frequency and characteristics. Thromb Haemost. 87:575–579. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Trousseau A: Plegmasia alba dolens.
Lectures on clinical medicine. (delivered at the Hotel-Dieu, Paris,
Vol. 5. The New Sydenham Society, London). 281–332. 1865.PubMed/NCBI
|
|
37
|
Wolberg AS, Aleman MM, Leiderman K and
Machlus KR: Procoagulant activity in hemostasis and thrombosis:
Virchow's triad revisited. Anesth Analg. 114:275–285. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wojtukiewicz MZ, Sierko E, Klement P and
Rak J: The hemostatic system and angiogenesis in malignancy.
Neoplasia. 3:371–384. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Larsen AC, Dabrowski T, Frøkjær JB, Fisker
RV, Iyer VV, Møller BK, Kristensen SR and Thorlacius-Ussing O:
Prevalence of venous thromboembolism at diagnosis of upper
gastrointestinal cancer. Br J Surg. 101:246–253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Quinn DA, Thompson BT, Terrin ML, Thrall
JH, Athanasoulis CA, McKusick KA, Stein PD and Hales CA: A
prospective investigation of pulmonary embolism in women and men.
JAMA. 268:1689–1696. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cogo A, Bernardi E, Prandoni P, Girolami
B, Noventa F, Simioni P and Girolami A: Acquired risk factors for
deep-vein thrombosis in symptomatic outpatients. Arch Intern Med.
154:164–168. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Goldhaber SZ, Savage DD, Garrison RJ,
Castelli WP, Kannel WB, McNamara PM, Gherardi G and Feinleib M:
Risk factors for pulmonary embolism: The framingham study. Am J
Med. 74:1023–1028. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Goldhaber SZ, Grodstein F, Stampfer MJ,
Manson JE, Colditz GA, Speizer FE, Willett WC and Hennekens CH: A
prospective study of risk factors for pulmonary embolism in women.
JAMA. 277:642–645. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Walker AJ, West J, Card TR, Crooks C,
Kirwan CC and Grainge MJ: When are breast cancer patients at
highest risk of venous thromboembolism? A cohort study using
English health care data. Blood. 127:849–857. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Debourdeau P, Espié M, Chevret S, Gligorov
J, Elias A, Dupré PF, Desseaux K, Kalidi I, Villiers S, Giachetti
S, et al: Incidence, risk factors, and outcomes of central venous
catheter-related thromboembolism in breast cancer patients: The
CAVECCAS study. Cancer Med. 6:2732–2744. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jones D, Wismayer K, Bozas G, Palmer J,
Elliott M and Maraveyas A: The risk of venous thromboembolism
associated with peripherally inserted central catheters in ambulant
cancer patients. Thromb J. 15:252017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Larsen AC, Frøkjær JB, Fisker RV, Iyer V,
Mortensen PB, Yilmaz MK, Møller B, Kristensen SR and
Thorlacius-Ussing O: Treatment-related frequency of venous
thrombosis in lower esophageal, gastro-esophageal and gastric
cancer-a clinical prospective study of outcome and prognostic
factors. Thromb Res. 135:802–808. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Haddad TC and Greeno EW:
Chemotherapy-induced thrombosis. Thromb Res. 118:555–568. 2016.
View Article : Google Scholar
|
|
49
|
Bertoglio S, Faccini B, Lalli L, Cafiero F
and Bruzzi P: Peripherally inserted central catheters (PICCs) in
cancer patients under chemotherapy: A prospective study on the
incidence of complications and overall failures. J Surg Oncol.
113:708–714. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
O'Brien J, Paquet F, Lindsay R and Valenti
D: Insertion of PICCs with minimum number of lumens reduces
complications and costs. J Am Coll Radiol. 10:864–868. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sud R and Khorana AA: Cancer-associated
thrombosis: Risk factors, candidate biomarkers and a risk model.
Thromb Res. 123 (Suppl 4):S18–S21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shivakumar SP, Anderson DR and Couban S:
Catheter-associated thrombosis in patients with malignancy. J Clin
Oncol. 27:4858–4864. 2009. View Article : Google Scholar : PubMed/NCBI
|
